Backed by $4M raise, BioPhy is using AI to predict successful clinical trials
The Center City company founded by Wharton grads has two artificial intelligence-powered products to determine the success of new drugs and clinical trials, as well as help bring drugs to market more quickly.
Source: technical.ly